John J. Nemunaitis

机构：Gradalis (United States) · ORCID：0000-0002-2234-2381

发表论文 804 篇 · 总被引 36315 次 · h-index 93

代表论文

Randomized Phase II Trial Comparing Bevacizumab Plus Carboplatin and Paclitaxel With Carboplatin and Paclitaxel Alone in Previously Untreated Locally Advanced or Metastatic Non-Small-Cell Lung Cancer (2023 · Journal of Clinical Oncology · 被引 121)
Smart exosomes enhance PDAC targeted therapy (2024 · Journal of Controlled Release · 被引 59)
Regulatory role of CD39 and CD73 in tumor immunity (2024 · Future Oncology · 被引 46)
Advances in Targeted Therapy for the Treatment of Cervical Cancer (2023 · Journal of Clinical Medicine · 被引 38)
Clonal Neoantigen: Emerging “Mechanism-based” Biomarker of Immunotherapy Response (2023 · Cancers · 被引 13)
First-in-human dose-escalation study of NBF-006, a novel investigational siRNA targeting GSTP, in patients with non-small cell lung, pancreatic, or colorectal cancer. (2023 · Journal of Clinical Oncology · 被引 13)